Literature DB >> 24848202

Mind the gap: understanding the effects of pharmaceutical direct-to-consumer advertising.

Kevin M Fain1, G Caleb Alexander.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24848202      PMCID： PMC4031617          DOI： 10.1097/MLR.0000000000000126

Source DB:  PubMed          Journal:  Med Care        ISSN： 0025-7079            Impact factor:   2.983


× No keyword cloud information.
  8 in total

Review 1.  Benefits and harms of direct to consumer advertising: a systematic review.

Authors:  S Gilbody; P Wilson; I Watt
Journal:  Qual Saf Health Care       Date:  2005-08

2.  Creating demand for prescription drugs: a content analysis of television direct-to-consumer advertising.

Authors:  Dominick L Frosch; Patrick M Krueger; Robert C Hornik; Peter F Cronholm; Frances K Barg
Journal:  Ann Fam Med       Date:  2007 Jan-Feb       Impact factor: 5.166

3.  Content analysis of false and misleading claims in television advertising for prescription and nonprescription drugs.

Authors:  Adrienne E Faerber; David H Kreling
Journal:  J Gen Intern Med       Date:  2014-01       Impact factor: 5.128

4.  Rethinking opioid prescribing to protect patient safety and public health.

Authors:  G Caleb Alexander; Stefan P Kruszewski; Daniel W Webster
Journal:  JAMA       Date:  2012-11-14       Impact factor: 56.272

5.  Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial.

Authors:  Richard L Kravitz; Ronald M Epstein; Mitchell D Feldman; Carol E Franz; Rahman Azari; Michael S Wilkes; Ladson Hinton; Peter Franks
Journal:  JAMA       Date:  2005-04-27       Impact factor: 56.272

6.  Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality.

Authors:  J W Peabody; J Luck; P Glassman; T R Dresselhaus; M Lee
Journal:  JAMA       Date:  2000-04-05       Impact factor: 56.272

7.  A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising.

Authors:  Dominick L Frosch; David Grande; Derjung M Tarn; Richard L Kravitz
Journal:  Am J Public Health       Date:  2010-01       Impact factor: 9.308

8.  Promotion of prescription drugs to consumers and providers, 2001-2010.

Authors:  Rachel Kornfield; Julie Donohue; Ernst R Berndt; G Caleb Alexander
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240
  8 in total
  11 in total

1.  Effect of Direct-to-Consumer Advertising on Asthma Medication Sales and Healthcare Use.

Authors:  Matthew Daubresse; Susan Hutfless; Yoonsang Kim; Rachel Kornfield; Dima M Qato; Jidong Huang; Kay Miller; Sherry L Emery; G Caleb Alexander
Journal:  Am J Respir Crit Care Med       Date:  2015-07-01       Impact factor: 21.405

2.  Direct to consumer advertising: the case for greater consumer control.

Authors:  Idris Guessous; Chiranjeev Dash
Journal:  J Gen Intern Med       Date:  2015-04       Impact factor: 5.128

3.  Key Features of Academic Detailing: Development of an Expert Consensus Using the Delphi Method.

Authors:  James S Yeh; Thomas J Van Hoof; Michael A Fischer
Journal:  Am Health Drug Benefits       Date:  2016-02

4.  Trends in exposure to televised prescription drug advertising, 2003-2011.

Authors:  Rachel Kornfield; G Caleb Alexander; Dima M Qato; Yoonsang Kim; Jan D Hirsch; Sherry L Emery
Journal:  Am J Prev Med       Date:  2015-05       Impact factor: 5.043

5.  Polypharmacy: a healthcare conundrum with a pharmacogenetic solution.

Authors:  Cierra N Sharp; Mark W Linder; Roland Valdes
Journal:  Crit Rev Clin Lab Sci       Date:  2019-11-02       Impact factor: 6.250

Review 6.  Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.

Authors:  Keith Humphreys; Chelsea L Shover; Christina M Andrews; Amy S B Bohnert; Margaret L Brandeau; Jonathan P Caulkins; Jonathan H Chen; Mariano-Florentino Cuéllar; Yasmin L Hurd; David N Juurlink; Howard K Koh; Erin E Krebs; Anna Lembke; Sean C Mackey; Lisa Larrimore Ouellette; Brian Suffoletto; Christine Timko
Journal:  Lancet       Date:  2022-02-02       Impact factor: 202.731

7.  Acceptability of a primary care-based opioid and pain review service: a mixed-methods evaluation in England.

Authors:  Joanna M Kesten; Kyla Thomas; Lauren J Scott; Kevin Bache; Matthew Hickman; Rona Campbell; Anthony E Pickering; Sabi Redwood
Journal:  Br J Gen Pract       Date:  2020-01-30       Impact factor: 5.386

Review 8.  Oxycodone in the Opioid Epidemic: High 'Liking', 'Wanting', and Abuse Liability.

Authors:  Cherkaouia Kibaly; Jacob A Alderete; Steven H Liu; Hazem S Nasef; Ping-Yee Law; Christopher J Evans; Catherine M Cahill
Journal:  Cell Mol Neurobiol       Date:  2020-11-27       Impact factor: 4.231

Review 9.  Pain Therapy Guided by Purpose and Perspective in Light of the Opioid Epidemic.

Authors:  Amie L Severino; Arash Shadfar; Joshua K Hakimian; Oliver Crane; Ganeev Singh; Keith Heinzerling; Wendy M Walwyn
Journal:  Front Psychiatry       Date:  2018-04-23       Impact factor: 4.157

10.  Evaluation of a primary care-based opioid and pain review service: a mixed-methods evaluation in two GP practices in England.

Authors:  Lauren J Scott; Joanna M Kesten; Kevin Bache; Matthew Hickman; Rona Campbell; Anthony E Pickering; Sabi Redwood; Kyla Thomas
Journal:  Br J Gen Pract       Date:  2020-01-30       Impact factor: 5.386
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.